157 related articles for article (PubMed ID: 19429301)
1. Intraoperative therapy with liposomal drug delivery: retention and distribution in human head and neck squamous cell carcinoma xenograft model.
Wang SX; Bao A; Phillips WT; Goins B; Herrera SJ; Santoyo C; Miller FR; Otto RA
Int J Pharm; 2009 May; 373(1-2):156-64. PubMed ID: 19429301
[TBL] [Abstract][Full Text] [Related]
2. Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery.
Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Vile RG; Stewart JS
Clin Cancer Res; 2000 Jun; 6(6):2528-37. PubMed ID: 10873109
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable polymer-mediated intratumoral delivery of cisplatin for treatment of human head and neck squamous cell carcinoma in a chimeric mouse model.
Chen FA; Kuriakose MA; Zhou MX; DeLacure MD; Dunn RL
Head Neck; 2003 Jul; 25(7):554-60. PubMed ID: 12808659
[TBL] [Abstract][Full Text] [Related]
4. Isolation of a peptide for targeted drug delivery into human head and neck solid tumors.
Hong FD; Clayman GL
Cancer Res; 2000 Dec; 60(23):6551-6. PubMed ID: 11118031
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies.
Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Abra RM; Stewart JS
Br J Cancer; 2000 Jul; 83(2):232-8. PubMed ID: 10901376
[TBL] [Abstract][Full Text] [Related]
6. Targeting of a head and neck squamous cell carcinoma xenograft model using the chimeric monoclonal antibody U36 radioiodinated with a closo-dodecaborate-containing linker.
Cheng J; Persson M; Tolmachev V; Siavaev I; Orlova A; Kairemo K; Anniko M
Acta Otolaryngol; 2004 Nov; 124(9):1078-85. PubMed ID: 15513553
[TBL] [Abstract][Full Text] [Related]
7. Tissue distribution of liposome-mediated epidermal growth factor receptor antisense gene therapy.
Thomas SM; Zeng Q; Dyer KF; Suscovich TJ; Kanter PM; Whalen JD; Watkins SF; Grandis JR
Cancer Gene Ther; 2003 Jul; 10(7):518-28. PubMed ID: 12833132
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.
de Bree R; Roos JC; Quak JJ; den Hollander W; Snow GB; van Dongen GA
Clin Cancer Res; 1995 Jun; 1(6):591-8. PubMed ID: 9816020
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterisation and biodistribution of 99mTc-labeled liposome encapsulated cyclosporine.
Arulsudar N; Subramanian N; Mishra P; Sharma RK; Murthy RS
J Drug Target; 2003 Apr; 11(3):187-96. PubMed ID: 13129826
[TBL] [Abstract][Full Text] [Related]
10. Direct 99mTc labeling of pegylated liposomal doxorubicin (Doxil) for pharmacokinetic and non-invasive imaging studies.
Bao A; Goins B; Klipper R; Negrete G; Phillips WT
J Pharmacol Exp Ther; 2004 Feb; 308(2):419-25. PubMed ID: 14610219
[TBL] [Abstract][Full Text] [Related]
11. Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors.
Lim HJ; Masin D; McIntosh NL; Madden TD; Bally MB
J Pharmacol Exp Ther; 2000 Jan; 292(1):337-45. PubMed ID: 10604968
[TBL] [Abstract][Full Text] [Related]
12. A simple and efficient method for radiolabeling of preformed liposomes.
Suresh M; Cao Y
J Pharm Pharm Sci; 1998; 1(1):31-7. PubMed ID: 10942970
[TBL] [Abstract][Full Text] [Related]
13. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size.
Kong G; Braun RD; Dewhirst MW
Cancer Res; 2000 Aug; 60(16):4440-5. PubMed ID: 10969790
[TBL] [Abstract][Full Text] [Related]
14. Effect of intratumoral administration on biodistribution of 64Cu-labeled nanoshells.
Xie H; Goins B; Bao A; Wang ZJ; Phillips WT
Int J Nanomedicine; 2012; 7():2227-38. PubMed ID: 22619558
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of sterically stabilized liposomes as a vehicle for targeting technetium-99m labelled radiopharmaceuticals.
Kumar S; Singh T; Khar RK; Sharma SN; Chauhan UP
Pharmazie; 1993 Aug; 48(8):613-6. PubMed ID: 8415859
[TBL] [Abstract][Full Text] [Related]
16. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.
Dams ET; Laverman P; Oyen WJ; Storm G; Scherphof GL; van Der Meer JW; Corstens FH; Boerman OC
J Pharmacol Exp Ther; 2000 Mar; 292(3):1071-9. PubMed ID: 10688625
[TBL] [Abstract][Full Text] [Related]
17. Fusaric acid: a novel agent and mechanism to treat HNSCC.
Stack BC; Hansen JP; Ruda JM; Jaglowski J; Shvidler J; Hollenbeak CS
Otolaryngol Head Neck Surg; 2004 Jul; 131(1):54-60. PubMed ID: 15243558
[TBL] [Abstract][Full Text] [Related]
18. Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma.
Buchholz J; Kaser-Hotz B; Khan T; Rohrer Bley C; Melzer K; Schwendener RA; Roos M; Walt H
Clin Cancer Res; 2005 Oct; 11(20):7538-44. PubMed ID: 16243829
[TBL] [Abstract][Full Text] [Related]
19. [Effect of liposome on permeability and drug retention of sodium fluorescein in rat skin: an experimental study].
Xie YS; Zeng K; Li GF; Dong P; Shi YM; Zhu XL; Sun LD; Hou GR
Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):110-3. PubMed ID: 12581954
[TBL] [Abstract][Full Text] [Related]
20. Engineered liposomes for potential alpha-particle therapy of metastatic cancer.
Sofou S; Thomas JL; Lin HY; McDevitt MR; Scheinberg DA; Sgouros G
J Nucl Med; 2004 Feb; 45(2):253-60. PubMed ID: 14960644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
